Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 182 entries
Sorted by: Best Match Show Resources per page
The effect of social media (#SoMe) on journal impact factor and parental awareness in paediatric urology.

Journal of pediatric urology

O'Kelly F, Nason GJ, Manecksha RP, Cascio S, Quinn FJ, Leonard M, Koyle MA, Farhat W, Leveridge MJ.
PMID: 28483467
J Pediatr Urol. 2017 Oct;13(5):513.e1-513.e7. doi: 10.1016/j.jpurol.2017.03.027. Epub 2017 Apr 21.

BACKGROUND: Social media (SoMe) comprises a number of internet-based applications that have the capability to disseminate multimodal media and allow for unprecedented inter-user connectivity. The role of Twitter has been studied in conferences and education; moreover, there is increasing...

Cite
O'Kelly F, Nason GJ, Manecksha RP, et al. The effect of social media (#SoMe) on journal impact factor and parental awareness in paediatric urology. J Pediatr Urol. 2017;13(5):513.e1-513.e7doi: 10.1016/j.jpurol.2017.03.027.
O'Kelly, F., Nason, G. J., Manecksha, R. P., Cascio, S., Quinn, F. J., Leonard, M., Koyle, M. A., Farhat, W., & Leveridge, M. J. (2017). The effect of social media (#SoMe) on journal impact factor and parental awareness in paediatric urology. Journal of pediatric urology, 13(5), 513.e1-513.e7. https://doi.org/10.1016/j.jpurol.2017.03.027
O'Kelly, F, et al. "The effect of social media (#SoMe) on journal impact factor and parental awareness in paediatric urology." Journal of pediatric urology vol. 13,5 (2017): 513.e1-513.e7. doi: https://doi.org/10.1016/j.jpurol.2017.03.027
O'Kelly F, Nason GJ, Manecksha RP, Cascio S, Quinn FJ, Leonard M, Koyle MA, Farhat W, Leveridge MJ. The effect of social media (#SoMe) on journal impact factor and parental awareness in paediatric urology. J Pediatr Urol. 2017 Oct;13(5):513.e1-513.e7. doi: 10.1016/j.jpurol.2017.03.027. Epub 2017 Apr 21. PMID: 28483467.
Copy Download .nbib Format: NLM
Growing the Field: Current Approaches to Data Collection at Farmers' Markets.

Journal of hunger & environmental nutrition

Karpyn A, Kim SA, DaCosta RV, Gasinu S, Law YM.
PMID: 27134690
J Hunger Environ Nutr. 2012;7(4):436-448. doi: 10.1080/19320248.2012.732924. Epub 2012 Dec 10.

There is limited published research about the dietary impacts of farmers' markets. We sought to understand whether market managers collect data about markets and to examine the instruments and strategies used. Of the 359 market managers contacted across the...

Cite
Karpyn A, Kim SA, DaCosta RV, et al. Growing the Field: Current Approaches to Data Collection at Farmers' Markets. J Hunger Environ Nutr. 2012;7(4):436-448doi: 10.1080/19320248.2012.732924.
Karpyn, A., Kim, S. A., DaCosta, R. V., Gasinu, S., & Law, Y. M. (2012). Growing the Field: Current Approaches to Data Collection at Farmers' Markets. Journal of hunger & environmental nutrition, 7(4), 436-448. https://doi.org/10.1080/19320248.2012.732924
Karpyn, Allison, et al. "Growing the Field: Current Approaches to Data Collection at Farmers' Markets." Journal of hunger & environmental nutrition vol. 7,4 (2012): 436-448. doi: https://doi.org/10.1080/19320248.2012.732924
Karpyn A, Kim SA, DaCosta RV, Gasinu S, Law YM. Growing the Field: Current Approaches to Data Collection at Farmers' Markets. J Hunger Environ Nutr. 2012;7(4):436-448. doi: 10.1080/19320248.2012.732924. Epub 2012 Dec 10. PMID: 27134690; PMCID: PMC4850835.
Copy Download .nbib Format: NLM
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

Oncoscience

Amantini C, Morelli MB, Santoni M, Soriani A, Cardinali C, Farfariello V, Eleuteri AM, Bonfili L, Mozzicafreddo M, Nabissi M, Cascinu S, Santoni G.
PMID: 26097873
Oncoscience. 2015 Mar 23;2(4):395-409. doi: 10.18632/oncoscience.147. eCollection 2015.

Sorafenib, a tyrosine kinase inhibitor, has been demonstrated to exert anti-tumor effects. However, the molecular mechanisms underlying its effects on bladder cancer remain unknown. Here, we evaluated the mechanisms responsible for the sorafenib-induced anti-tumor effects on 5637 and T24...

Cite
Amantini C, Morelli MB, Santoni M, et al. Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. Oncoscience. 2015;2(4):395-409doi: 10.18632/oncoscience.147.
Amantini, C., Morelli, M. B., Santoni, M., Soriani, A., Cardinali, C., Farfariello, V., Eleuteri, A. M., Bonfili, L., Mozzicafreddo, M., Nabissi, M., Cascinu, S., & Santoni, G. (2015). Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. Oncoscience, 2(4), 395-409. https://doi.org/10.18632/oncoscience.147
Amantini, Consuelo, et al. "Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells." Oncoscience vol. 2,4 (2015): 395-409. doi: https://doi.org/10.18632/oncoscience.147
Amantini C, Morelli MB, Santoni M, Soriani A, Cardinali C, Farfariello V, Eleuteri AM, Bonfili L, Mozzicafreddo M, Nabissi M, Cascinu S, Santoni G. Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. Oncoscience. 2015 Mar 23;2(4):395-409. doi: 10.18632/oncoscience.147. eCollection 2015. PMID: 26097873; PMCID: PMC4468325.
Copy Download .nbib Format: NLM
Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma.

La Radiologia medica

Giovagnoni A, Ottaviani L, Mensà A, Durastanti M, Floriani I, Cascinu S.
PMID: 15883519
Radiol Med. 2005 Apr;109(4):345-57.

PURPOSE: A) To define the role of diagnostic imaging modalities in the follow-up of patients after surgery for solid cancer, using an Evidence Based Medicine (EBM) approach; B) to assess the possible discrepancies between the theoretical model and the...

Cite
Giovagnoni A, Ottaviani L, Mensà A, et al. Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma. Radiol Med. 2005;109(4):345-57
Giovagnoni, A., Ottaviani, L., Mensà, A., Durastanti, M., Floriani, I., & Cascinu, S. (2005). Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma. La Radiologia medica, 109(4), 345-57.
Giovagnoni, Andrea, et al. "Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma." La Radiologia medica vol. 109,4 (2005): 345-57.
Giovagnoni A, Ottaviani L, Mensà A, Durastanti M, Floriani I, Cascinu S. Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma. Radiol Med. 2005 Apr;109(4):345-57. Italian. PMID: 15883519.
Copy Download .nbib Format: NLM
Midline Spikes Associated with Focal Epilepsy.

Epilepsy currents

Cascino G.
PMID: 15309138
Epilepsy Curr. 2002 Jul;2(4):116-118. doi: 10.1046/j.1535-7597.2002.t01-1-00044.x.

No abstract available.

Cite
Cascino G. Midline Spikes Associated with Focal Epilepsy. Epilepsy Curr. 2002;2(4):116-118doi: 10.1046/j.1535-7597.2002.t01-1-00044.x.
Cascino, G. (2002). Midline Spikes Associated with Focal Epilepsy. Epilepsy currents, 2(4), 116-118. https://doi.org/10.1046/j.1535-7597.2002.t01-1-00044.x
Cascino, Gregory. "Midline Spikes Associated with Focal Epilepsy." Epilepsy currents vol. 2,4 (2002): 116-118. doi: https://doi.org/10.1046/j.1535-7597.2002.t01-1-00044.x
Cascino G. Midline Spikes Associated with Focal Epilepsy. Epilepsy Curr. 2002 Jul;2(4):116-118. doi: 10.1046/j.1535-7597.2002.t01-1-00044.x. PMID: 15309138; PMCID: PMC321035.
Copy Download .nbib Format: NLM
Carboplatin associated anemia treated with subcutaneous erythropoietin - a pilot-study.

Oncology reports

Cascinu S, Fedeli A, Delferro E, Fedeli S, Catalano G.
PMID: 21607330
Oncol Rep. 1994 Jan;1(1):169-72.

In nineteen patients with carboplatin-induced anemia (hemoglobin less than 90 g/l), recombinant human erythropoietin was administered subcutaneously three times a week on an outpatient basis. The initial dose was 50 Units/kg of body weight. If response was not achieved...

Cite
Cascinu S, Fedeli A, Delferro E, et al. Carboplatin associated anemia treated with subcutaneous erythropoietin - a pilot-study. Oncol Rep. 1994;1(1):169-72
Cascinu, S., Fedeli, A., Delferro, E., Fedeli, S., & Catalano, G. (1994). Carboplatin associated anemia treated with subcutaneous erythropoietin - a pilot-study. Oncology reports, 1(1), 169-72.
Cascinu, S, et al. "Carboplatin associated anemia treated with subcutaneous erythropoietin - a pilot-study." Oncology reports vol. 1,1 (1994): 169-72.
Cascinu S, Fedeli A, Delferro E, Fedeli S, Catalano G. Carboplatin associated anemia treated with subcutaneous erythropoietin - a pilot-study. Oncol Rep. 1994 Jan;1(1):169-72. PMID: 21607330.
Copy Download .nbib Format: NLM
Investigations into the hypothesis of transgenic cannabis.

Journal of forensic sciences

Cascini F.
PMID: 22211569
J Forensic Sci. 2012 May;57(3):718-21. doi: 10.1111/j.1556-4029.2011.02021.x. Epub 2011 Dec 28.

The unusual concentration of cannabinoids recently found in marijuana samples submitted to the forensic laboratory for chemical analysis prompted an investigation into whether genetic modifications have been made to the DNA of Cannabis sativa L. to increase its potency....

Cite
Cascini F. Investigations into the hypothesis of transgenic cannabis. J Forensic Sci. 2011;57(3):718-21doi: 10.1111/j.1556-4029.2011.02021.x.
Cascini, F. (2012). Investigations into the hypothesis of transgenic cannabis. Journal of forensic sciences, 57(3), 718-21. https://doi.org/10.1111/j.1556-4029.2011.02021.x
Cascini, Fidelia. "Investigations into the hypothesis of transgenic cannabis." Journal of forensic sciences vol. 57,3 (2012): 718-21. doi: https://doi.org/10.1111/j.1556-4029.2011.02021.x
Cascini F. Investigations into the hypothesis of transgenic cannabis. J Forensic Sci. 2012 May;57(3):718-21. doi: 10.1111/j.1556-4029.2011.02021.x. Epub 2011 Dec 28. PMID: 22211569.
Copy Download .nbib Format: NLM
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study.

Oncology letters

Santoni M, Paccapelo A, Burattini L, Bianconi M, Cardinali M, Fabbietti L, Trignani R, Rychlicki F, Cascinu S.
PMID: 23205103
Oncol Lett. 2012 Oct;4(4):799-801. doi: 10.3892/ol.2012.788. Epub 2012 Jul 05.

O(6)-alkylguanine-DNA alkyltransferase (AGAT), involved in temozolomide-induced DNA damage repair, plays a key role in the efficacy of temozolomide. AGAT activity may be reduced by protracted temozolomide doses. On the basis of the preclinical findings, we treated patients with a...

Cite
Santoni M, Paccapelo A, Burattini L, et al. Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncol Lett. 2012;4(4):799-801doi: 10.3892/ol.2012.788.
Santoni, M., Paccapelo, A., Burattini, L., Bianconi, M., Cardinali, M., Fabbietti, L., Trignani, R., Rychlicki, F., & Cascinu, S. (2012). Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncology letters, 4(4), 799-801. https://doi.org/10.3892/ol.2012.788
Santoni, Matteo, et al. "Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study." Oncology letters vol. 4,4 (2012): 799-801. doi: https://doi.org/10.3892/ol.2012.788
Santoni M, Paccapelo A, Burattini L, Bianconi M, Cardinali M, Fabbietti L, Trignani R, Rychlicki F, Cascinu S. Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncol Lett. 2012 Oct;4(4):799-801. doi: 10.3892/ol.2012.788. Epub 2012 Jul 05. PMID: 23205103; PMCID: PMC3506588.
Copy Download .nbib Format: NLM
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.

Cancers

Toss A, Venturelli M, Molinaro E, Pipitone S, Barbieri E, Marchi I, Tenedini E, Artuso L, Castellano S, Marino M, Tagliafico E, Razzaboni E, De Matteis E, Cascinu S, Cortesi L.
PMID: 30736435
Cancers (Basel). 2019 Feb 07;11(2). doi: 10.3390/cancers11020193.

The identification of BRCA mutations plays a crucial role in the management of hereditary cancer prevention and treatment. Nonetheless, BRCA-testing in pancreatic cancer (PC) patients is not universally introduced in clinical practice. A retrospective analysis was conducted, firstly, to...

Cite
Toss A, Venturelli M, Molinaro E, et al. Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies. Cancers (Basel). 2019;11(2)doi: 10.3390/cancers11020193.
Toss, A., Venturelli, M., Molinaro, E., Pipitone, S., Barbieri, E., Marchi, I., Tenedini, E., Artuso, L., Castellano, S., Marino, M., Tagliafico, E., Razzaboni, E., De Matteis, E., Cascinu, S., & Cortesi, L. (2019). Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies. Cancers, 11(2), . https://doi.org/10.3390/cancers11020193
Toss, Angela, et al. "Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies." Cancers vol. 11,2 (2019). doi: https://doi.org/10.3390/cancers11020193
Toss A, Venturelli M, Molinaro E, Pipitone S, Barbieri E, Marchi I, Tenedini E, Artuso L, Castellano S, Marino M, Tagliafico E, Razzaboni E, De Matteis E, Cascinu S, Cortesi L. Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies. Cancers (Basel). 2019 Feb 07;11(2). doi: 10.3390/cancers11020193. PMID: 30736435; PMCID: PMC6406586.
Copy Download .nbib Format: NLM
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.

Cancer management and research

Omarini C, Palumbo P, Pecchi A, Draisci S, Balduzzi S, Nasso C, Barbolini M, Isca C, Bocconi A, Moscetti L, Galetti S, Tazzioli G, Torricelli P, Cascinu S, Piacentini F.
PMID: 32009814
Cancer Manag Res. 2019 Nov 12;11:9563-9569. doi: 10.2147/CMAR.S216034. eCollection 2019.

BACKGROUND: Fat tissue is strongly involved in BC tumorigenesis inducing insulin resistance, chronic inflammation and hormonal changes. Computed tomography (CT) imaging instead of body mass index (BMI) gives a reliable measure of skeletal muscle mass and body fat distribution....

Cite
Omarini C, Palumbo P, Pecchi A, et al. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Cancer Manag Res. 2019;11:9563-9569doi: 10.2147/CMAR.S216034.
Omarini, C., Palumbo, P., Pecchi, A., Draisci, S., Balduzzi, S., Nasso, C., Barbolini, M., Isca, C., Bocconi, A., Moscetti, L., Galetti, S., Tazzioli, G., Torricelli, P., Cascinu, S., & Piacentini, F. (2019). Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Cancer management and research, 119563-9569. https://doi.org/10.2147/CMAR.S216034
Omarini, Claudia, et al. "Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy." Cancer management and research vol. 11 (2019): 9563-9569. doi: https://doi.org/10.2147/CMAR.S216034
Omarini C, Palumbo P, Pecchi A, Draisci S, Balduzzi S, Nasso C, Barbolini M, Isca C, Bocconi A, Moscetti L, Galetti S, Tazzioli G, Torricelli P, Cascinu S, Piacentini F. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Cancer Manag Res. 2019 Nov 12;11:9563-9569. doi: 10.2147/CMAR.S216034. eCollection 2019. PMID: 32009814; PMCID: PMC6859164.
Copy Download .nbib Format: NLM
ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation.

ESC heart failure

Srinivasan D, Strohbehn GW, Cascino T.
PMID: 28772029
ESC Heart Fail. 2017 Aug;4(3):384-386. doi: 10.1002/ehf2.12161. Epub 2017 Mar 23.

Angiotensin-converting enzyme inhibitor induced angioedema commonly involves the head and neck area. We report a case of angiotensin-converting enzyme inhibitor induced intestinal angioedema in a heart transplant recipient on mTOR immunosuppression. A 36-year-old Caucasian woman with history of heart...

Cite
Srinivasan D, Strohbehn GW, Cascino T. ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC Heart Fail. 2017;4(3):384-386doi: 10.1002/ehf2.12161.
Srinivasan, D., Strohbehn, G. W., & Cascino, T. (2017). ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC heart failure, 4(3), 384-386. https://doi.org/10.1002/ehf2.12161
Srinivasan, Dushyanth, et al. "ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation." ESC heart failure vol. 4,3 (2017): 384-386. doi: https://doi.org/10.1002/ehf2.12161
Srinivasan D, Strohbehn GW, Cascino T. ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC Heart Fail. 2017 Aug;4(3):384-386. doi: 10.1002/ehf2.12161. Epub 2017 Mar 23. PMID: 28772029; PMCID: PMC5542730.
Copy Download .nbib Format: NLM
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial.

Therapeutic advances in medical oncology

Caccialanza R, Cereda E, Klersy C, Brugnatelli S, Borioli V, Ferrari A, Caraccia M, Lobascio F, Pagani A, Delfanti S, Aprile G, Reni M, Rimassa L, Melisi D, Cascinu S, Battistini L, Candiloro F, Pedrazzoli P.
PMID: 32127922
Ther Adv Med Oncol. 2020 Feb 22;12:1758835919890281. doi: 10.1177/1758835919890281. eCollection 2020.

BACKGROUND: Malnutrition is common in cancer patients, particularly in those affected by gastrointestinal malignancies, and negatively affects treatment tolerance, survival, functional status, and quality of life (QoL). Nutritional support, including supplemental parenteral nutrition (SPN), has been recommended at the...

Cite
Caccialanza R, Cereda E, Klersy C, et al. Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial. Ther Adv Med Oncol. 2020;12:1758835919890281doi: 10.1177/1758835919890281.
Caccialanza, R., Cereda, E., Klersy, C., Brugnatelli, S., Borioli, V., Ferrari, A., Caraccia, M., Lobascio, F., Pagani, A., Delfanti, S., Aprile, G., Reni, M., Rimassa, L., Melisi, D., Cascinu, S., Battistini, L., Candiloro, F., & Pedrazzoli, P. (2020). Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial. Therapeutic advances in medical oncology, 121758835919890281. https://doi.org/10.1177/1758835919890281
Caccialanza, Riccardo, et al. "Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial." Therapeutic advances in medical oncology vol. 12 (2020): 1758835919890281. doi: https://doi.org/10.1177/1758835919890281
Caccialanza R, Cereda E, Klersy C, Brugnatelli S, Borioli V, Ferrari A, Caraccia M, Lobascio F, Pagani A, Delfanti S, Aprile G, Reni M, Rimassa L, Melisi D, Cascinu S, Battistini L, Candiloro F, Pedrazzoli P. Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial. Ther Adv Med Oncol. 2020 Feb 22;12:1758835919890281. doi: 10.1177/1758835919890281. eCollection 2020. PMID: 32127922; PMCID: PMC7036492.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 182 entries